![](/img/cover-not-exists.png)
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
Feldman, Steven R., Thaçi, Diamant, Gooderham, Melinda, Augustin, Matthias, Cruz, Claudia de la, Mallbris, Lotus, Buonanno, Marjorie, Tatulych, Svitlana, Kaur, Mandeep, Lan, Shuping, Valdez, Hernan, MLanguage:
english
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2016.07.040
Date:
September, 2016
File:
PDF, 675 KB
english, 2016